Cancer Network
January 10, 2023
Results from a phase 3 trial led by Genescopy find a stool-based, non-invasive, at-home test aimed at detecting colorectal cancer and advanced adenomas yielded high sensitivity and specificity results. David Lieberman, M.D., says: “Geneoscopy’s test and the positive clinical trial results are promising because patients need additional convenient options that will accurately detect colon cancer, as well as advanced adenomas, before patients have cancer. If we can identify patients with advanced adenomas and remove those lesions, many cancers can be prevented.”